From: A survey of knowledge, perceptions and use of core outcome sets among clinical trialists
 | Median | Range | IQR |
---|---|---|---|
COS are the minimum that should be measured for specific health or health care area | 4 | 1–5 | 4 |
COS are the minimum that should be reported for specific health or health care area | 4 | 1–5 | 4 |
All outcomes in the COS should be measured | 4 | 1–5 | 2 |
Other outcomes can be measured in addition to outcomes in COS | 5 | 2–5 | 1 |
COS can be used in research other than trials (e.g. evidence synthesis, observational studies) | 5 | 3–5 | 1 |
COS are relevant to clinical audit and routine care | 4 | 3–5 | 1 |
COS can involve input from relevant stakeholders | 5 | 3–5 | 1 |
COS require consensus processes in development | 5 | 2–5 | 1 |
Development of a COS involves multiple stages | 5 | 4–5 | 0.75 |
Understanding of what COS are | 4 | 2–5 | 1 |
Perceived importance of COS in clinical trials | 3 | 2–3 | 1 |